GENEDX ($WGS) posted quarterly earnings results on Tuesday, October 28th. The company reported earnings of $0.49 per share, beating estimates of $0.43 by $0.06. The company also reported revenue of $116,740,000, beating estimates of $105,716,700 by $11,023,300.
You can see Quiver Quantitative's $WGS stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
GENEDX Insider Trading Activity
GENEDX insiders have traded $WGS stock on the open market 49 times in the past 6 months. Of those trades, 3 have been purchases and 46 have been sales.
Here’s a breakdown of recent trading of $WGS stock by insiders over the last 6 months:
- CAPITAL, LLC CASDIN sold 500,000 shares for an estimated $60,451,950
- KATHERINE STUELAND (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 19 sales selling 58,341 shares for an estimated $5,727,058.
- KEITH A. MEISTER has made 3 purchases buying 100,000 shares for an estimated $5,600,994 and 0 sales.
- JASON RYAN has made 0 purchases and 7 sales selling 39,222 shares for an estimated $4,995,800.
- KEVIN FEELEY (CHIEF FINANCIAL OFFICER) has made 0 purchases and 19 sales selling 24,750 shares for an estimated $2,437,370.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
GENEDX Hedge Fund Activity
We have seen 145 institutional investors add shares of GENEDX stock to their portfolio, and 110 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 18,848,488 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,739,903,927
- FMR LLC removed 2,630,629 shares (-94.2%) from their portfolio in Q2 2025, for an estimated $242,833,362
- PENTWATER CAPITAL MANAGEMENT LP added 1,188,000 shares (+3712.5%) to their portfolio in Q2 2025, for an estimated $109,664,280
- UBS GROUP AG added 949,579 shares (+1821.2%) to their portfolio in Q2 2025, for an estimated $87,655,637
- CORVEX MANAGEMENT LP added 584,848 shares (+23.6%) to their portfolio in Q2 2025, for an estimated $53,987,318
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. added 533,383 shares (+105.9%) to their portfolio in Q2 2025, for an estimated $49,236,584
- WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC added 442,414 shares (+37.2%) to their portfolio in Q2 2025, for an estimated $40,839,236
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
GENEDX Analyst Ratings
Wall Street analysts have issued reports on $WGS in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 10/22/2025
- Piper Sandler issued a "Overweight" rating on 09/11/2025
- Guggenheim issued a "Buy" rating on 06/30/2025
- Jefferies issued a "Buy" rating on 05/09/2025
To track analyst ratings and price targets for GENEDX, check out Quiver Quantitative's $WGS forecast page.
GENEDX Price Targets
Multiple analysts have issued price targets for $WGS recently. We have seen 6 analysts offer price targets for $WGS in the last 6 months, with a median target of $127.5.
Here are some recent targets:
- Mark Massaro from BTIG set a target price of $140.0 on 10/22/2025
- Kyle Mikson from Canaccord Genuity set a target price of $155.0 on 10/20/2025
- David Westenberg from Piper Sandler set a target price of $140.0 on 09/11/2025
- Brandon Couillard from Wells Fargo set a target price of $95.0 on 07/30/2025
- Subbu Nambi from Guggenheim set a target price of $115.0 on 06/30/2025
- Tycho Peterson from Jefferies set a target price of $80.0 on 05/09/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
